Amphastar Pharmaceuticals Inc recorded an increase in cost of sales by 2.85 % year on year, relative to one quarter ago cost of sales fell by -10.33 % in Q2.
Amphastar Pharmaceuticals Inc recorded increase in cost of sales by 2.85 % year on year, compare to one quarter ago cost of sales fell by -10.33 % in Q2.
Amphastar Pharmaceuticals Inc's Comment on Supply Chain
The company specializes in sourcing, synthesizing, and manufacturing raw materials and active pharmaceutical ingredients (APIs) where it holds a competitive advantage. It has pursued strategic acquisitions to strengthen its manufacturing, marketing, and research and development capabilities, including the production of starting materials, APIs, and other product components. The company focuses on high-barrier markets such as injectables and inhalation products, which demand advanced manufacturing processes and compliance with current Good Manufacturing Practices (cGMP). The injectable market is affected by supply constraints linked to quality issues among manufacturers, while the inhalation market requires reformulation and technical engineering due to evolving delivery technologies. The company utilizes its integrated capabilities to compete in these specialized markets.
Amphastar Pharmaceuticals Inc's Comment on Supply Chain
The company specializes in sourcing, synthesizing, and manufacturing raw materials and active pharmaceutical ingredients (APIs) where it holds a competitive advantage. It has pursued strategic acquisitions to strengthen its manufacturing, marketing, and research and development capabilities, including the production of starting materials, APIs, and other product components. The company focuses on high-barrier markets such as injectables and inhalation products, which demand advanced manufacturing processes and compliance with current Good Manufacturing Practices (cGMP). The injectable market is affected by supply constraints linked to quality issues among manufacturers, while the inhalation market requires reformulation and technical engineering due to evolving delivery technologies. The company utilizes its integrated capabilities to compete in these specialized markets.
Sources:
Amphastar Pharmaceuticals Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Amphastar Pharmaceuticals Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
